Cargando…
Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy
The benefit of adjuvant trastuzumab in disease-free and overall survival for human epidermal receptor 2–positive (HER2+) breast cancer patients is well established. However, the effect of trastuzumab on locoregional control remains unclear, particularly in patients treated with adjuvant radiotherapy...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985293/ https://www.ncbi.nlm.nih.gov/pubmed/27512838 http://dx.doi.org/10.1097/MD.0000000000004230 |